Skip to main content
Clinical Trials/NCT00935233
NCT00935233
Unknown
N/A

ICICLE- A Study to Investigate the genetiCs of In Situ Carcinoma of the ductaL subtypE

Queen Mary University of London18 sites in 1 country6,000 target enrollmentJuly 2008
ConditionsBreast Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Queen Mary University of London
Enrollment
6000
Locations
18
Primary Endpoint
Collection of blood and/or tumor tissue
Last Updated
12 years ago

Overview

Brief Summary

RATIONALE: Studying genes in samples of blood and/or tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood and/or tumor tissue samples from patients with ductal carcinoma in situ and blood samples from healthy volunteers.

Detailed Description

OBJECTIVES: Primary * To collect blood and/or tumor tissue of patients with ductal breast carcinoma in situ (DCIS) and their age- and ethnicity-matched controls to identify the inherited variation that predisposes women to develop DCIS. * To determine the frequency of these variants. * To determine the effect of these variants on tumor risk. * To determine the benefit of testing for these variants in the clinical setting so that those at higher risk could be identified, counseled, and screened. Secondary * To analyze the acquired genetic changes within DCIS to identify which cases are more likely to develop invasive disease. OUTLINE: This is a multicenter study. All participants complete a questionnaire to collect their family history, a brief medical history, and epidemiological data. Patients undergo collection of blood and/or tumor tissue samples; DNA is extracted for genotyping, comparison of allele and genotype frequencies (polymorphisms), genetic profiling, DNA analysis, and protein analysis. Histopathology reports are also collected. Healthy volunteers undergo collection of blood samples. PROJECTED ACCRUAL: A minimum of 3,000 patients and 3,000 controls will be accrued for this study.

Registry
clinicaltrials.gov
Start Date
July 2008
End Date
July 2010
Last Updated
12 years ago
Study Type
Observational
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Collection of blood and/or tumor tissue

Frequency of genetic variants that predispose women to develop ductal carcinoma in situ (DCIS)

Effect of these variants on tumor risk

Benefit of testing for these variants

Secondary Outcomes

  • Analysis of acquired genetic changes within DCIS

Study Sites (18)

Loading locations...

Similar Trials